resonance imaging (MRI) scans suggestive of multiple sclerosis are at high risk for clinically
definite multiple sclerosis, but the outcome for individual patients is unpredictable. An
increased risk of progression to clinically definite multiple sclerosis in patients with serum
antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein
(MBP) has been reported. Methods We measured serum anti-MOG and anti-MBP IgG and …